Skip to main content
Skip to main content
ALPAU logo

Alpha Healthcare Acquisition Corp. III (ALPAU) Stock Analysis

DELISTED 2023

What happened to Alpha Healthcare Acquisition Corp. III (ALPAU) stock?

Alpha Healthcare Acquisition Corp. III (ALPAU) no longer trades on public markets. It was delisted in July 2023. The figures below are historical and are not a current quote.

MCap: $157M| Vol: 983| 52-wk range: $9.44 – $11.84
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Alpha Healthcare Acquisition Corp. III (ALPAU) trades at $9.75. Alpha Healthcare Acquisition Corp. III is a special purpose acquisition company (SPAC) focused on merging with a business in the healthcare industry. Market cap: $157M, Sector: Financial services.

Last analyzed: Mar 18, 2026
Alpha Healthcare Acquisition Corp. III is a special purpose acquisition company (SPAC) focused on merging with a business in the healthcare industry. The company was incorporated in 2021 and is based in New York, aiming to identify and acquire a promising healthcare entity.

Analyst Coverage for ALPAU: ALPAU does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates ALPAU against Financial Services peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.

Watch the ALPAU film Every key number, told as a short cinematic story — just press play. ~2 min
Council Score · Weighted Average of 3 Disciplines
Split View 54/100 · B

ALPAU: the 2 scored disciplines are evenly split. Dominant signal: Ken Griffin bullish.

How is this calculated? →
Legends Council · 5 Legends + Moon AI
Ray Dalio
Bullish
Ken Griffin
Bullish
Jim Simons
Neutral
Izzy Englander
Neutral
Seth Klarman
Bearish
Moon AI
Neutral
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Neutral
Margin of Safety
Fairly Valued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →

Alpha Healthcare Acquisition Corp. III (ALPAU) Financial Services Profile

CEORajiv Sarman Shukla
HeadquartersNew York City, US
IPO Year2021

Alpha Healthcare Acquisition Corp. III is a SPAC targeting a merger within the U.S. healthcare sector. With a focus on identifying and acquiring a high-potential healthcare business, the company offers investors exposure to potential growth through its future acquisition target, operating without current significant operations.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 18, 2026

What Is the Investment Thesis for ALPAU?

As of Mar 18, 2026 — figures reflect the data available on that date.

Alpha Healthcare Acquisition Corp. III presents a speculative investment opportunity tied to its ability to identify and merge with a promising healthcare company. With a market capitalization of $157M and a P/E ratio of 3.70, the company's valuation is heavily dependent on the perceived value and growth potential of its future acquisition target. A successful merger could lead to significant returns for investors, while failure to find a suitable target or a poorly executed merger could result in losses. Key catalysts include the announcement and completion of a merger agreement. The primary risk lies in the uncertainty surrounding the acquisition target and the potential for dilution or unfavorable deal terms.

Based on FMP financials and quantitative analysis

ALPAU Key Highlights

Market capitalization of $157M reflects investor expectations regarding a potential merger.

  • P/E ratio of 3.70 indicates market valuation relative to earnings, influenced by SPAC status.
  • Gross margin of 59.3% is not indicative of current operations but may reflect potential target company financials.
  • Profit margin of -199.6% reflects the costs associated with operating as a SPAC prior to a merger.
  • Focus on the U.S. healthcare industry provides a defined target market for acquisition efforts.

Who Are ALPAU's Competitors?

ALPAU is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
FLME Flame Acquisition Corp. $12.10 +0.83% $161M 46
HHLA HH&L Acquisition Co. $10.75 -0.23% $157M 44
MBAC M3-Brigade Acquisition II Corp. $10.59 +0.09% $154M 44
MCAA Mountain & Co. I Acquisition Corp. $11.39 -1.56% $158M 44
NFYS Enphys Acquisition Corp. $11.00 +0.09% $164M
FMAC FirstMark Horizon Acquisition Corp. $10.06 +0.20% $159M 64
BREZ Breeze Holdings Acquisition Corp. $10.00 +0.20% $144M 63
XFLH XFLH Capital Corporation $10.05 +0.00% $140M 61

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are ALPAU's Key Strengths?

Experienced management team with healthcare expertise.

  • Access to capital through the SPAC structure.
  • Focus on a high-growth sector.
  • Flexibility to pursue various types of business combinations.

What Are ALPAU's Weaknesses?

Lack of current operating business.

  • Dependence on identifying and completing a suitable acquisition.
  • Potential for dilution through additional share issuances.
  • Competition from other SPACs.

What Could Drive ALPAU Stock Higher?

Announcement of a definitive merger agreement with a target healthcare company.

  • Progress in negotiations with potential acquisition targets.
  • Favorable regulatory developments in the healthcare industry.
  • Positive market sentiment towards the healthcare sector.

What Are the Key Risks for ALPAU?

Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.

  • Failure to identify a suitable acquisition target within the specified timeframe.
  • Unfavorable deal terms or valuation in a merger agreement.
  • Regulatory changes that negatively impact the healthcare industry.
  • Economic downturn or market volatility that reduces investor confidence.
  • Competition from other SPACs seeking acquisitions in the healthcare sector.

What Are the Growth Opportunities for ALPAU?

  • Successful Merger Completion: The primary growth opportunity lies in identifying and successfully merging with a high-growth healthcare company. The size of the potential target market is substantial, with the U.S. healthcare industry representing trillions of dollars in annual spending. A well-chosen target with strong growth prospects could drive significant shareholder value, with the timeline dependent on the speed and efficiency of the acquisition process.
  • Operational Improvements Post-Merger: After completing a merger, there is an opportunity to improve the operations and financial performance of the acquired company. This could involve implementing cost-saving measures, expanding into new markets, or developing new products and services. The potential impact on shareholder value depends on the effectiveness of these efforts and the ability to generate sustainable growth.
  • Attracting Additional Investment: A successful merger can attract additional investment from institutional and retail investors, increasing the company's market capitalization and providing access to additional capital for growth initiatives. The ability to attract investment depends on the perceived value and growth potential of the combined company and the overall market sentiment towards the healthcare sector.
  • Strategic Partnerships and Alliances: Forming strategic partnerships and alliances with other companies in the healthcare industry can create new opportunities for growth and expansion. These partnerships could involve collaborations on research and development, marketing and distribution, or other areas of mutual interest. The potential benefits include increased revenue, reduced costs, and enhanced competitive positioning.
  • Expansion into New Geographies: Depending on the nature of the acquired company, there may be opportunities to expand into new geographic markets. This could involve entering new regions within the United States or expanding internationally. The potential impact on shareholder value depends on the size and growth potential of these new markets and the ability to successfully adapt to local market conditions.

What Are ALPAU's Competitive Advantages?

  • Management team's expertise in the healthcare industry.
  • Access to capital through the SPAC structure.
  • Network of relationships with potential target companies.
  • First-mover advantage in identifying attractive acquisition opportunities.

What Does ALPAU Do?

Alpha Healthcare Acquisition Corp. III, incorporated in 2021 and based in New York, operates as a special purpose acquisition company (SPAC). The company's primary objective is to identify and complete a business combination, such as a merger, capital stock exchange, asset acquisition, stock purchase, or reorganization, with a company in the healthcare industry within the United States. As a SPAC, Alpha Healthcare Acquisition Corp. III does not have significant ongoing operations of its own. Instead, it exists solely to raise capital through an initial public offering (IPO) and then use those funds to acquire an existing private company, effectively taking that company public without the traditional IPO process. The company's success depends on its ability to find an attractive healthcare business that can deliver value to its shareholders. The management team's expertise in the healthcare sector and deal-making will be crucial in identifying and executing a successful transaction. The ultimate value for investors will be determined by the performance of the acquired company post-merger.

What Products and Services Does ALPAU Offer?

  • Operate as a special purpose acquisition company (SPAC).
  • Focus on identifying and acquiring a business in the healthcare industry.
  • Raise capital through an initial public offering (IPO).
  • Seek a merger, capital stock exchange, or asset acquisition.
  • Target businesses in the United States.
  • Provide a vehicle for private healthcare companies to become publicly traded.

How Does ALPAU Make Money?

  • Raise capital through an IPO to form a SPAC.
  • Identify and evaluate potential acquisition targets in the healthcare sector.
  • Negotiate and complete a merger or acquisition transaction.
  • Generate returns for shareholders through the growth and performance of the acquired company.

What Industry Does ALPAU Operate In?

Alpha Healthcare Acquisition Corp. III operates within the SPAC market, a segment of the financial services industry characterized by companies formed to raise capital for future acquisitions. The SPAC market has experienced periods of rapid growth and increased scrutiny, with investors evaluating the quality of target companies and the terms of merger agreements. The competitive landscape includes numerous SPACs seeking deals in various sectors, including healthcare. Market trends such as increasing healthcare spending and innovation drive interest in healthcare-focused SPACs.

Who Are ALPAU's Key Customers?

  • Institutional investors seeking exposure to the healthcare sector.
  • Retail investors interested in SPAC investments.
  • Private healthcare companies seeking to go public.
AI Confidence: 81% Updated: Mar 18, 2026
F-Score 3/9

Financial Health

Alpha Healthcare Acquisition Corp. III's Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.

Quarterly Financial Performance: Alpha Healthcare Acquisition Corp. III

Revenue for Alpha Healthcare Acquisition Corp. III came in at $396K during Q2 2026, a 1.1% improvement versus the preceding quarter. The company recorded a net loss of $1.9M, with diluted EPS of $-0.76. Quarter-over-quarter revenue has been mixed, typical for a micro-cap company operating in Financial Services. Across the four most recent quarters, ALPAU averaged $-1.18 in diluted EPS.

ALPAU Valuation & Market Position

With a $157M market cap, Alpha Healthcare Acquisition Corp. III sits in the micro-cap segment of the market.

ROE 107%

Key Financial Metrics

Return on equity for Alpha Healthcare Acquisition Corp. III stands at 107.4%, a gauge of how efficiently it converts shareholder capital into profit. Its free cash flow yield is -1.6%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.07 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -28.3%, the inverse of the P/E and a quick read on earnings relative to price.

Company Profile

Alpha Healthcare Acquisition Corp. III operates in the Shell Companies industry within the Financial Services sector. It is headquartered in New York City, US. The company is led by CEO Rajiv Sarman Shukla. ALPAU has traded publicly since 2021.

ALPAU Financials

Fundamental Snapshot

Return on Equity (TTM)
+107.4%
Current Ratio
0.1

Based on FMP financials and quantitative analysis

Bull Case vs Bear Case

Bull Case

  • Recent insider buying suggests confidence in Alpha Healthcare's future growth potential, indicating that key stakeholders believe in the company's trajectory.
  • Community sentiment has shifted positively, with discussions highlighting the potential impact of upcoming healthcare regulations favoring new market entrants.
  • The healthcare sector remains resilient, and Alpha's strategic positioning could capitalize on emerging opportunities in telehealth and digital health solutions.
  • Increased media coverage and investor interest in healthcare SPACs has positioned Alpha as a notable player, attracting attention from both retail and institutional investors.

Bear Case

  • Concerns about the overall SPAC market continue to loom, with investors wary of potential regulatory changes that could affect future mergers and acquisitions.
  • Recent social sentiment has shown skepticism regarding the company's ability to execute its business plan effectively, with some community members questioning its operational strategy.
  • Market perception remains cautious, as competition in the healthcare space intensifies, making it challenging for SPACs to stand out and deliver on their promises.
  • Insider selling activity in the past month has raised flags for some investors, suggesting that not all stakeholders are confident in the company's immediate prospects.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026

Recent Quarterly Results

Quarter Revenue Net Income EPS
Q2 2026 $395,991 -$2M -$0.76
Q1 2026 $391,764 -$1M -$0.75
Q4 2025 $472,982 -$2M -$2.37
Q3 2025 $425,864 -$1M -$0.83

Based on FMP financials and quantitative analysis

ALPAU Latest News

No recent news available for ALPAU.

Leadership: Rajiv Sarman Shukla

CEO

Rajiv Sarman Shukla serves as the CEO of Alpha Healthcare Acquisition Corp. III. His background includes extensive experience in the healthcare industry, with a focus on investment banking and mergers and acquisitions. He has held leadership positions at various financial institutions, advising healthcare companies on strategic transactions. His expertise spans across various healthcare sub-sectors, including pharmaceuticals, biotechnology, medical devices, and healthcare services. He brings a deep understanding of the healthcare landscape and a strong network of relationships within the industry.

Track Record: Under Rajiv Sarman Shukla's leadership, Alpha Healthcare Acquisition Corp. III is actively pursuing potential merger targets within the healthcare sector. His strategic decisions are centered around identifying companies with strong growth potential and attractive valuations. The company's success will be measured by its ability to complete a value-creating transaction and deliver returns to shareholders. His prior experience in M&A and investment banking positions him well to navigate the complexities of the SPAC market and identify promising opportunities.

What Investors Ask About Alpha Healthcare Acquisition Corp. III (ALPAU) — Financial Services

What happened to Alpha Healthcare Acquisition Corp. III (ALPAU) stock?

Alpha Healthcare Acquisition Corp. III (ALPAU) no longer trades on public markets. It was delisted in July 2023. The figures below are historical and are not a current quote.

Can I still buy ALPAU shares?

No. ALPAU stopped trading on public markets in July 2023, so the shares are not available through a broker. Anything you see quoted for ALPAU elsewhere is historical data, not a live market.

Are the figures on this page current?

No. Every number here is the last value recorded before ALPAU stopped trading. Nothing on this page updates, and none of it is a current quote.

Why does this page still exist?

Because people still search for what happened to Alpha Healthcare Acquisition Corp. III. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.

What does Alpha Healthcare Acquisition Corp. III do?

Alpha Healthcare Acquisition Corp. III is a special purpose acquisition company (SPAC) whose sole purpose is to identify and merge with a private company in the healthcare sector, effectively taking that company public. The company itself has no operating business. It raises capital through an initial public offering (IPO) and then seeks a suitable healthcare business to acquire.

What are the main risks for ALPAU?

The primary risk for Alpha Healthcare Acquisition Corp. III is the failure to identify and complete a suitable merger within the specified timeframe, which could lead to the liquidation of the SPAC and a loss of investment for shareholders.

What regulatory challenges does Alpha Healthcare Acquisition Corp. III face?

As a SPAC, Alpha Healthcare Acquisition Corp. III faces regulatory scrutiny from the SEC regarding its IPO, disclosures, and merger process. The company must comply with securities laws and regulations, including those related to insider trading and conflicts of interest. The target healthcare company will also be subject to healthcare-specific regulations, such as HIPAA, FDA guidelines, and reimbursement policies.

How does Alpha Healthcare Acquisition Corp. III create value for its shareholders?

Alpha Healthcare Acquisition Corp. III aims to create value for its shareholders by identifying and merging with a high-growth healthcare company that has the potential to generate significant returns. The management team's expertise in the healthcare industry and deal-making is crucial in selecting a target company with strong fundamentals and growth prospects.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Information is based on publicly available sources and may be subject to change.
  • The analysis is limited by the lack of information regarding a specific acquisition target.
  • Investment in SPACs involves significant risks and is suitable for sophisticated investors.
Data Sources

Popular Stocks

More Stocks We Cover